miRNA-21 (miR-21) shows promise in reducing myocardial infarct size and cardiomyocyte apoptosis during acute myocardial infarction [166], and aids cardiovascular regeneration by regulating target genes like programmed cell death 4 (PDCD4) [167,168]. This evidence concerns the gene PDCD4 and myocardial infarction.